Aza-THIP

Aza-THIP
Clinical data
Other namesAzagaboxadol
Drug classGABAA antagonist
ATC code
  • None
Identifiers
  • 1,2,4,5,6,7-hexahydropyrazolo[3,4-c]pyridin-3-one
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC6H9N3O
Molar mass139.158 g·mol−1
3D model (JSmol)
  • C1CNCC2=C1C(=O)NN2
  • InChI=1S/C6H9N3O/c10-6-4-1-2-7-3-5(4)8-9-6/h7H,1-3H2,(H2,8,9,10)
  • Key:UPMMUUFLHUEUKP-UHFFFAOYSA-N

Aza-THIP is a selective and moderately potent GABAA (GABAC receptor) antagonist related to gaboxadol (THIP).[1][2][3][4] Unlike gaboxadol, it is virtually inactive at the GABAA receptor.[1][2][4][5] The drug was first described in the scientific literature by Povl Krogsgaard-Larsen and colleagues by 1979.[6][7]

See also

[edit]

References

[edit]
  1. ^ a b Krogsgaard-Larsen P, Frølund B, Liljefors T (2006). "GABAA Agonists and Partial Agonists: THIP (Gaboxadol) as a Non-Opioid Analgesic and a Novel Type of Hypnotic1". GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic. Advances in Pharmacology. Vol. 54. pp. 53–71. doi:10.1016/s1054-3589(06)54003-7. ISBN 978-0-12-032957-1. PMID 17175810.
  2. ^ a b Johnston GA, Chebib M, Hanrahan JR, Mewett KN (August 2003). "GABA(C) receptors as drug targets". Current Drug Targets. CNS and Neurological Disorders. 2 (4): 260–268. doi:10.2174/1568007033482805. PMID 12871036.
  3. ^ Johnston GA, Chebib M, Hanrahan JR, Mewett KN (December 2010). "Neurochemicals for the investigation of GABA(C) receptors". Neurochemical Research. 35 (12): 1970–1977. doi:10.1007/s11064-010-0271-7. PMID 20963487.
  4. ^ a b Krehan D, Frølund B, Ebert B, Nielsen B, Krogsgaard-Larsen P, Johnston GA, et al. (November 2003). "Aza-THIP and related analogues of THIP as GABA C antagonists". Bioorganic & Medicinal Chemistry. 11 (23): 4891–4896. doi:10.1016/j.bmc.2003.09.016. PMID 14604650.
  5. ^ Frølund B, Ebert B, Kristiansen U, Liljefors T, Krogsgaard-Larsen P (August 2002). "GABA(A) receptor ligands and their therapeutic potentials". Current Topics in Medicinal Chemistry. 2 (8): 817–832. doi:10.2174/1568026023393525. PMID 12171573.
  6. ^ Krogsgaard-Larsen P, Falch E (August 1981). "GABA agonists. Development and interactions with the GABA receptor complex". Molecular and Cellular Biochemistry. 38 Spec No (Pt 1): 129–146. doi:10.1007/BF00235692. PMID 6270544.
  7. ^ Krogsgaard-Larsen P, Roldskov-Christiansen T (1979). "GABA agonists. Synthesis and structure-activity studies on analogs of isoguvacine and THIP". Chimica Therapeutica (European Journal of Medicinal Chemistry). 14: 157–164.